Johnson & Johnson Total Assets
Johnson & Johnson (JNJ) had Total Assets of $201.06 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-23
- 2026-06-28: Assets $201.06B.
- 2026-03-29: Assets $200.89B.
- 2025-12-28: Assets $199.21B.
- 2025-09-28: Assets $192.82B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-28 | $201.06B 10-Q · filed 2026-07-23 | |
| 2026-03-29 | $200.89B 10-Q · filed 2026-04-22 | |
| 2025-12-28 | $199.21B 10-Q · filed 2026-07-23 | |
| 2025-09-28 | $192.82B 10-Q · filed 2025-10-22 | |
| 2025-06-29 | $193.39B 10-Q · filed 2025-07-24 | |
| 2025-03-30 | $193.67B 10-Q · filed 2025-04-23 | |
| 2024-12-29 | $180.10B 10-K · filed 2026-02-11 | |
| 2024-09-29 | $178.29B 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $181.09B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $171.97B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $167.56B 10-K · filed 2025-02-13 | |
| 2023-10-01 | $166.06B 10-Q · filed 2023-10-27 | |
| 2023-07-02 | $191.69B 10-Q · filed 2023-07-31 | |
| 2023-04-02 | $195.97B 10-Q · filed 2023-04-28 | |
| 2023-01-01 | $187.38B 10-K · filed 2024-02-16 | |
| 2022-10-02 | $175.12B 10-Q · filed 2022-10-27 | |
| 2022-07-03 | $177.72B 10-Q · filed 2022-07-29 | |
| 2022-04-03 | $178.35B 10-Q · filed 2022-04-29 | |
| 2022-01-02 | $182.02B 10-K · filed 2023-02-16 | |
| 2021-10-03 | $179.23B 10-Q · filed 2021-10-29 | |
| 2021-07-04 | $176.44B 10-Q · filed 2021-07-29 | |
| 2021-04-04 | $172.56B 10-Q · filed 2021-04-30 | |
| 2021-01-03 | $174.89B 10-K · filed 2022-02-17 | |
| 2020-09-27 | $170.69B 10-Q · filed 2020-10-23 | |
| 2020-06-28 | $158.38B 10-Q · filed 2020-07-24 | |
| 2020-03-29 | $155.02B 10-Q · filed 2020-04-29 | |
| 2019-12-29 | $157.73B 10-K · filed 2021-02-22 | |
| 2019-09-29 | $155.52B 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $155.12B 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $150.03B 10-Q · filed 2019-05-01 | |
| 2018-12-30 | $152.95B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $155.70B 10-Q · filed 2018-10-31 | |
| 2018-07-01 | $155.37B 10-Q · filed 2018-08-02 | |
| 2018-04-01 | $156.63B 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $157.30B 10-K · filed 2019-02-20 | |
| 2017-10-01 | $155.66B 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $152.81B 10-Q · filed 2017-08-03 | |
| 2017-04-02 | $144.92B 10-Q · filed 2017-05-08 | |
| 2017-01-01 | $141.21B 10-K · filed 2018-02-21 | |
| 2016-10-02 | $140.37B 10-Q · filed 2016-11-04 | |
| 2016-07-03 | $139.81B 10-Q · filed 2016-08-04 | |
| 2016-04-03 | $136.23B 10-Q · filed 2016-05-10 | |
| 2016-01-03 | $133.41B 10-K · filed 2017-02-27 | |
| 2015-09-27 | $133.27B 10-Q · filed 2015-10-30 | |
| 2015-06-28 | $132.04B 10-Q · filed 2015-07-31 | |
| 2015-03-29 | $128.59B 10-Q · filed 2015-05-01 | |
| 2014-12-28 | $130.36B 10-K · filed 2016-02-24 | $131.12B 10-K · filed 2015-02-24 |
| 2014-09-28 | $132.10B 10-Q · filed 2014-10-30 | |
| 2014-06-29 | $135.20B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $133.33B 10-Q · filed 2014-05-02 | |
| 2013-12-29 | $132.68B 10-K · filed 2015-02-24 | |
| 2013-09-29 | $126.93B 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $124.33B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $121.54B 10-Q · filed 2013-05-03 | |
| 2012-12-30 | $121.35B 10-K · filed 2015-02-24 | |
| 2012-09-30 | $118.95B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $115.75B 10-Q · filed 2012-08-02 | |
| 2012-04-01 | $116.19B 10-Q · filed 2012-05-07 | |
| 2012-01-01 | $113.64B 10-K · filed 2014-02-21 | |
| 2011-10-02 | $111.82B 10-Q · filed 2011-11-08 | |
| 2011-07-03 | $112.11B 10-Q · filed 2011-08-09 | |
| 2011-04-03 | $108.15B 10-Q · filed 2011-05-10 | |
| 2011-01-02 | $102.91B 10-K · filed 2013-02-22 | |
| 2010-10-03 | $98.25B 10-Q · filed 2010-11-10 | |
| 2010-07-04 | $92.30B 10-Q · filed 2010-08-11 | |
| 2010-04-04 | $93.44B 10-Q · filed 2010-05-10 | |
| 2010-01-03 | $94.68B 10-K · filed 2012-02-23 | |
| 2009-09-27 | $91.56B 10-Q · filed 2009-11-04 | |
| 2009-06-28 | $87.44B 10-Q · filed 2009-08-04 | |
| 2008-12-28 | $84.91B 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |